Friday, September 22, 2017 5:04:34 PM
EAPH/Canadian Alliance JV – Marijuana Grower/Greenhouses/Producer/Sales
EAPH/Canadian Alliance JV – Aggregate Sales - 6M +
EAPH/Gedeon Richter Big Pharma JV – Gynofit – South America
EAPH/Gideon Richter Big Pharma JV – AS Sense – South America
EAPH/Bayer Pharma Big Pharma JV – VS-Sense – Mexico/South America
EAPH/iBliss – Vapor/Cannabis Products/Sales
EAPH/Windsor Pharma – VS Sense – AL Sense – Central America/Carribean
EAPH/Health Products – Skin Renouha, Nauseasol, Kenestrin Gel, Viorra.
EAPH ADDITIONAL IMMINENT REVENUE STREAMS:
EAPH/AMFE – Potential JV, Additional EAPH Investment in AMFIL
EAPH/Cancer Drugs – Xlive – Docetael – Pacletaxel
EAPH/Topical Drug Delivery Formulation Gels
EAPH/Other Future Big Pharma and Worldwide MMJ JV’s
EAPH is Imminent in doing both Medical Marijuana and Recreational Marijuana production and sales worldwide with the Alliance Group JV on their 45 acre fully owned parcel of land for the cultivation, production and sale of medical marijuana to the cannabis industry, and would give Easton Pharmaceuticals a strong position into the pharmaceutical production/sales of Cannabis worldwide.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM